Semaphorin 3A promotes osteogenic differentiation in human alveolar bone marrow mesenchymal stem cells

Liu,Li; Wang,Jue; Song,Xiaomeng; Zhu,Qingping; Shen,Shuping; Zhang,Wei

doi:10.3892/etm.2018.5813

Semaphorin 3A promotes osteogenic differentiation in human alveolar bone marrow mesenchymal stem cells

Authors:
- Li Liu
- Jue Wang
- Xiaomeng Song
- Qingping Zhu
- Shuping Shen
- Wei Zhang
View Affiliations

Affiliations: Department of Prosthodontics, Shanghai Stomatological Hospital, Shanghai 200000, P.R. China, Department of Oral and Maxillofacial Surgery, Research Institute of Stomatology, Nanjing Medical University, Stomatological Hospital of Jiangsu Province, Nanjing, Jiangsu 210029, P.R. China, Department of Very Important People (VIP), Research Institute of Stomatology, Nanjing Medical University, Stomatological Hospital of Jiangsu Province, Nanjing, Jiangsu 210029, P.R. China
Published online on: January 30, 2018 https://doi.org/10.3892/etm.2018.5813
Pages: 3489-3494

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the role of Semaphorin 3A (Sema3A) in the osteogenic differentiation of human alveolar bone marrow mesenchymal stem cells (hABMMSCs). To investigate whether Sema3A affects hABMMSC proliferation and osteogenic differentiation, a stable Sema3A‑overexpression cell line was generated by infection with the pAdCMV-SEMA3A-MCS-EGFP vector. Cell counting kit‑8 and clone formation assays were performed to determine the proliferation ability of hABMMSCs, while cell osteogenic differentiation was assayed using Alizarin Red S staining. In addition, reverse transcription‑quantitative polymerase chain reaction was employed to detect the mRNA expression level of osteogenesis‑associated genes, Runt‑related transcription factor 2 (Runx2), osteopontin (Opn) and osteocalcin (Ocn), during the osteogenic differentiation. The results revealed that, compared with the normal control group, the cell morphology of the infected cells was stable and no significant alterations were observed. Overexpression of Sema3A in hABMMSCs significantly increased the cell proliferation ability compared with the control group. Furthermore, the Alizarin Red S staining assay results indicated that the ossification process of hABMMSCs overexpressing Sema3A was evidently faster in comparison with that of the control group cells. Overexpression of Sema3A by pAdCMV‑SEMA3A‑MCS‑EGFP infection also significantly increased the mRNA expression levels of the osteogenic marker genes Runx2, Opn and Ocn. In conclusion, Sema3A was observed to be a key positive regulator in hABMMSC osteogenic differentiation.

View Figures

View References

1	Tocci A and Forte L: Mesenchymal stem cell: Use and perspectives. Hematol J. 4:92–96. 2003. View Article : Google Scholar : PubMed/NCBI
2	Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, Kon E and Marcacci M: Repair of large bone effects with the use of autologous bone marrow stromal cells. N Engl J Med. 344:385–386. 2001. View Article : Google Scholar : PubMed/NCBI
3	Mauney JR, Volloch V and Kaplan DL: Role of adult mesenchymal stem cells in bone tissue engineering applications: Current status and future prospects. Tissue Eng. 11:787–802. 2005. View Article : Google Scholar : PubMed/NCBI
4	Tran TS, Kolodkin AL and Bharadwaj R: Semaphorin regulation of cellular morphology. Annu Rev Cell Dev Biol. 23:263–292. 2007. View Article : Google Scholar : PubMed/NCBI
5	Hinck L: The versatile roles of ‘axon guidance’ cues in tissue morphogenesis. Dev Cell. 7:783–793. 2004. View Article : Google Scholar : PubMed/NCBI
6	Behar O, Golden JA, Mashimo H, Schoen FJ and Fishman MC: Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature. 383:525–528. 1996. View Article : Google Scholar : PubMed/NCBI
7	Zhang Y, Singh MK, Degenhardt KR, Lu MM, Bennett J, Yoshida Y and Epstein JA: Tie2Cre-mediated inactivation of plexinD1 results in congenital heart, vascular and skeletal defects. Dev Biol. 325:82–93. 2009. View Article : Google Scholar : PubMed/NCBI
8	Reidy KJ, Villegas G, Teichman J, Veron D, Shen W, Jimenez J, Thomas D and Tufro A: Semaphorin3a regulates endothelial cell number and podocyte differentiation during glomerular development. Development. 136:3979–3989. 2009. View Article : Google Scholar : PubMed/NCBI
9	Neufeld G, Sabag AD, Rabinovicz N and Kessler O: Semaphorins in angiogenesis and tumor progression. Cold Spring Harb Perspect Med. 2:a0067182012. View Article : Google Scholar : PubMed/NCBI
10	Hota PK and Buck M: Plexin structures are coming: Opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions. Cell Mol Life Sci. 69:3765–3805. 2012. View Article : Google Scholar : PubMed/NCBI
11	Maione F, Capano S, Regano D, Zentilin L, Giacca M, Casanovas O, Bussolino F, Serini G and Giraudo E: Semaphorin3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice. J Clin Invest. 122:1832–1848. 2012. View Article : Google Scholar : PubMed/NCBI
12	Takamatsu H and Kumanogoh A: Diverse roles for semaphorin-plexin signaling in the immune system. Trends Immunol. 33:127–135. 2012. View Article : Google Scholar : PubMed/NCBI
13	Chakraborty G, Kumar S, Mishra R, Patil TV and Kundu GC: Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model. PLoS One. 7:e336332012. View Article : Google Scholar : PubMed/NCBI
14	Serini G, Maione F, Giraudo E and Bussolino F: Semaphorins and tumor angiogenesis. Angiogenesis. 12:187–193. 2009. View Article : Google Scholar : PubMed/NCBI
15	Maione F, Capano S, Regano D, Zentilin L, Giacca M, Casanovas O, Bussolino F, Serini G and Giraudo E: Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice. J Clin Invest. 122:1832–1848. 2012. View Article : Google Scholar : PubMed/NCBI
16	Gaur P, Bielenberg DR, Samuel S, Bose D, Zhou Y, Gray MJ, Dallas NA, Fan F, Xia L, Lu J and Ellis LM: Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis. Clin Cancer Res. 15:6763–6770. 2009. View Article : Google Scholar : PubMed/NCBI
17	Fukuda T, Takeda S, Xu R, Ochi H, Sunamura S, Sato T, Shibata S, Yoshida Y, Gu Z, Kimura A, et al: Sema3A regulates bone-mass accrual through sensory innervations. Nature. 497:490–493. 2013. View Article : Google Scholar : PubMed/NCBI
18	Hayashi M, Nakashima T, Taniguchi M, Kodama T, Kumanogoh A and Takayanagi H: Osteoprotection by semaphorin 3A. Nature. 485:69–74. 2012. View Article : Google Scholar : PubMed/NCBI
19	Zhang H, Cheng JQ, Huang Q, Yang J, Shen B, Zhou ZK, Kang PD, Lian YY and Pei FX: Increasing alcohol-induced osteogenesis of human bone marrow-derived mesenchymal cells using siRNA transient suppression of peroxisome proliferator activated receptor gamma: An in vitro experiment study. Zhonghua Yi Xue Za Zhi 88: 2603–2608, 2008. Zhonghua Yi Xue Za Zhi 88: 2603–2608, 2008. 88: 2603–2608, 2008:2603-2608, 2008–2608, 2008. 2008.(In Chinese).
20	Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP, Burge CB and Bartel DP: The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science. 310:1817–1821. 2005. View Article : Google Scholar : PubMed/NCBI
21	Cai Y, Xu MJ, Teng X, Zhou YB, Chen L, Zhu Y, Wang X, Tang CS and Qi YF: Intermedin inhibits vascular calcification by increasing the level of matrix gamma-carboxyglutamic acid protein. Cardiovasc Res. 85:864–873. 2010. View Article : Google Scholar : PubMed/NCBI
22	Kim BS, Kim YC, Zadeh H, Park YJ, Pi SH, Shin HS and You HK: Effects of the dichloromethane fraction of Dipsaci Radix on the osteoblastic differentiation of human alveolar bone marrow-derived mesenchymal stem cells. Biosci Biotechnol Biochem. 75:13–19. 2011. View Article : Google Scholar : PubMed/NCBI
23	Bates D, Taylor GI, Minichiello J, Farlie P, Cichowitz A, Watson N, Klagsbrun M, Mamluk R and Newgreen DF: Neurovascular congruence results from a shared patterning mechanism that utilizes Semaphorin3A and Neuropilin-1. Dev Biol. 255:77–98. 2003. View Article : Google Scholar : PubMed/NCBI
24	Serini G, Valdembri D, Zanivan S, Morterra G, Burkhardt C, Caccavari F, Zammataro L, Primo L, Tamagnone L, Logan M, et al: Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature. 424:391–397. 2003. View Article : Google Scholar : PubMed/NCBI
25	Gomez C, Burt-Pichat B, Mallein-Gerin F, Merle B, Delmas PD, Skerry TM, Vico L, Malaval L and Chenu C: Expression of Semaphorin-3A and its receptors in endochondral ossification: Potential role in skeletal development and innervation. Dev Dyn. 234:393–403. 2005. View Article : Google Scholar : PubMed/NCBI
26	Fang K, Song W, Wang L, Jia S, Wei H, Ren S, Xu X and Song Y: Immobilization of chitosan film containing semaphorin 3A onto a microarc oxidized titanium implant surface via silane reaction to improve MG63 osteogenic differentiation. Int J Nanomedicine. 9:4649–4657. 2014.PubMed/NCBI
27	Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB and Stein GS: Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol. 143:420–430. 1990. View Article : Google Scholar : PubMed/NCBI
28	Ducy P, Zhang R, Geoffroy V, Ridall AL and Karsenty G: Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell. 89:747–754. 1997. View Article : Google Scholar : PubMed/NCBI
29	Lian JB, Stein GS, Stein JL and van Wijnen AJ: Osteocalcin gene promoter: Unlocking the secrets for regulation of osteoblast growth and differentiation. J Cell Biochem Suppl 30–31. 1–72. 1998.
30	Donzelli E, Salvadè A, Mimo P, Viganò M, Morrone M, Papagna R, Carini F, Zaopo A, Miloso M, Baldoni M and Tredici G: Mesenchymal stem cells cultured on a collagen scaffold: In vitro osteogenic differentiation. Arch Oral Biol. 52:64–73. 2007. View Article : Google Scholar : PubMed/NCBI